Stocks Industrials ACAT
OTC · IndustrialsNP Life Sciences Health Industry Group Inc. (ACAT)
NP Life Sciences Health Industry Group Inc. reported revenue of $164.6K in fiscal 2023, up 61.4% from a year earlier. It posted a net loss of $2.9K. At December 31, 2023 it held $70.6K in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on April 16, 2024.
Watch ACAT in 60 secondsWhat NP Life Sciences Health Industry Group Inc. does
NP Life Sciences Health Industry Group Inc. is registered with the SEC under industry code SIC 8200 (Services-Educational Services). Its shares trade on OTC under the ticker ACAT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2023 | $164.6K | -$2.9K | $0.00 | n/a |
| 2022 | $102K | -$18.9K | $0.00 | n/a |
| 2021 | $35K | -$65.7K | $0.00 | n/a |
| 2020 | $15K | -$131.1K | $0.00 | n/a |
| 2019 | $43K | -$108.8K | $0.00 | n/a |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What NP Life Sciences Health Industry Group Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 21, 2024Deregistration 15-12G
- May 15, 2024Deregistration 15-12G
- April 16, 2024Annual report 10-K · period to December 31, 2023Revenue rose 61% to $164.6K versus the prior year; diluted EPS $0.00 versus $0.00.
- April 2, 2024Late annual report notice NT 10-K
- November 14, 2023Quarterly report 10-Q · period to September 30, 2023Revenue fell 57% to $17.5K versus the same quarter last year; net loss of $37.7K.
- August 14, 2023Quarterly report 10-Q · period to June 30, 2023Revenue rose 615% to $107.1K versus the same quarter last year; net income rose 6,504% to $71.2K.
- May 15, 2023
- April 18, 2023Annual report 10-K · period to December 31, 2022Revenue rose 192% to $102K versus the prior year; diluted EPS $0.00 versus $0.00.
- April 3, 2023Late annual report notice NT 10-K
- November 30, 2022Form DEF 14C filing DEF 14C
Questions about ACAT
What does NP Life Sciences Health Industry Group Inc. do?
NP Life Sciences Health Industry Group Inc. is registered with the SEC under industry code SIC 8200 (Services-Educational Services). Its shares trade on OTC under the ticker ACAT.
Is NP Life Sciences Health Industry Group Inc. profitable?
No. In fiscal 2023 it reported a net loss of $2.9K on revenue of $164.6K.
How much revenue does NP Life Sciences Health Industry Group Inc. make?
In fiscal 2023 NP Life Sciences Health Industry Group Inc. reported revenue of $164.6K. That is 61.4% more than a year earlier.
When did NP Life Sciences Health Industry Group Inc. last report?
Its most recent periodic report is the annual report (10-K) filed on April 16, 2024. It covers the period to December 31, 2023. Its newest filing of any kind is the deregistration from August 21, 2024.
Similar companies
Compare ACAT with
Follow ACAT
Get an email when NP Life Sciences Health Industry Group Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow ACAT: get an email when it filesWhere the numbers come from
Financial figures are the values NP Life Sciences Health Industry Group Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.